The American Cancer Society Cancer Action Network (ACS CAN) initiated an advertising campaign earlier this week to emphasize the importance of federal dollars in the fight against the deadly disease.
“Today’s Senate Special Committee on Aging hearing on the fight against cancer represents the first time in more than five years that Congress has focused specific attention on a disease expected to kill more than 585,000 people in America and cost the economy an estimated $216 billion this year.
“The bipartisan hearing brings important attention to the winnable fight against cancer and demonstrates the need to get federal investment in research back on track after years of static funding that has not kept pace with our potential for innovation.
“ACS CAN is launching a new advertising campaign this week emphasizing the lifesaving importance of federal funding for the National Cancer Institute. The ad, which appears in publications aimed at Capitol Hill, features Jacqueline Beale, a 12-year, two-time cancer survivor from Glenn Dale, MD Jacqueline, an ACS CAN volunteer advocate, holds a laboratory beaker in the ad, which asserts that research funding must be increased so promising discoveries can make it to the more than 1.6 million people who will be diagnosed with cancer this year.
Read the ACS CAN news release: http://bit.ly/1mI5zBh
Source: ACS CAN
FDA Approves Tislelizumab for Advanced or Metastatic ESCC After Chemotherapy
March 15th 2024The FDA has approved tislelizumab-jsgr (Tevimbra) for single-agent use in adult patients with unresectable or metastatic esophageal squamous cell carcinoma following prior systemic chemotherapy that did not include a PD-1/PD-L1 inhibitor.
Read More
Oncology Onward: A Conversation With Penn Medicine's Dr Justin Bekelman
December 19th 2023Justin Bekelman, MD, director of the Penn Center for Cancer Care Innovation, sat with our hosts Emeline Aviki, MD, MBA, and Stephen Schleicher, MD, MBA, for our final episode of 2023 to discuss the importance of collaboration between academic medicine and community oncology and testing innovative cancer care delivery in these settings.
Listen
QCCA, NCCA Merge to Form ONCare Among Independent Oncology Practices
February 29th 2024ONCare Alliance will be led by 2 of the leading women in community oncology, cochairs Barbara McAneny, MD, of the New Mexico Cancer Center, and Sibel Blau, MD, of Northwest Medical Specialties, PLLC, of Puyallup, Washington.
Read More